85-1444-69　Protein Kinase Inhibitor, aa14-22, Myristoylated (PKI) 1mg　P9103-75B

特徴

• Cell permeable cAMP-dependent protein kinase (PKA) inhibitor (protein kinase inhibitor, PKI). The non-myristoylated version of this peptide is a highly specific inhibitor of cAMP-dependent protein kinase (PKA).
• Peptide Content:85 ± 4%
• Amino Acid Sequence:Myr-Gly-Arg-Thr-Gly-Arg-Arg-Asn-Ala-Ile-NH2
• Amino Acid Analysis and Identity:Confirms
• Storage and Stability:Lyophilized powder may be stored at -20°C. Stable for 12 months at -20°C. Reconstitute with sterile dH2O. Aliquot to avoid repeated freezing and thawing. Store at -20°C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer.

仕様

• Size：1mg
• Grade：Highly Purified
• Purity：~95% (HPLC)
• Form：Supplied as a lyophilized powder from trifluoroacetate salt. Reconstitute with sterile ddH2O.
• Molecular Weight Non Ab：1209
• EU Commodity Code：38220090
• この商品は法規制を確認しておりません。(法規制によって販売できない場合もございます)
• 製品の仕様は予告なく変更になる場合がございます。最新仕様はメーカーホームページをご確認ください。

• 【試薬に関するお問合せ】
• アズワン株式会社 試薬・プロセス材料グループ
• TEL：06-6447-8641
• FAX：06-6447-8642
• E-mail：[email protected]